Entry |
|
Symbol |
PPP3CC, CALNA3, CNA3, PP2Bgamma
|
Name |
(RefSeq) protein phosphatase 3 catalytic subunit gamma
|
KO |
K04348 | serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] |
|
Organism |
|
Pathway |
hsa04625 | C-type lectin receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04658 | Th1 and Th2 cell differentiation |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa05022 | Pathways of neurodegeneration - multiple diseases |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Network |
nt06160 Human T-cell leukemia virus 1 (HTLV-1) nt06161 Human immunodeficiency virus 1 (HIV-1) nt06164 Kaposi sarcoma-associated herpesvirus (KSHV) nt06165 Epstein-Barr virus (EBV) nt06167 Human cytomegalovirus (HCMV) nt06220 Calcium signaling (cancer) nt06528 Calcium signaling nt06537 TCR/BCR signaling |
Element |
N00147 | EGF-EGFR-PLCG-calcineurin signaling pathway |
N00401 | CXCR4-GNAQ-PLCB/G-calcineurin signaling pathway |
N00487 | BCR-PLCG-Calcineurin signaling pathway |
N01647 | Ca2+/CAM-CN signaling pathway |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04310 Wnt signaling pathway
5533 (PPP3CC)
04022 cGMP-PKG signaling pathway
5533 (PPP3CC)
09150 Organismal Systems
09151 Immune system
04650 Natural killer cell mediated cytotoxicity
5533 (PPP3CC)
04660 T cell receptor signaling pathway
5533 (PPP3CC)
04658 Th1 and Th2 cell differentiation
5533 (PPP3CC)
04659 Th17 cell differentiation
5533 (PPP3CC)
04662 B cell receptor signaling pathway
5533 (PPP3CC)
09152 Endocrine system
04922 Glucagon signaling pathway
5533 (PPP3CC)
04921 Oxytocin signaling pathway
5533 (PPP3CC)
04924 Renin secretion
5533 (PPP3CC)
09156 Nervous system
04724 Glutamatergic synapse
5533 (PPP3CC)
04728 Dopaminergic synapse
5533 (PPP3CC)
04720 Long-term potentiation
5533 (PPP3CC)
09158 Development and regeneration
04360 Axon guidance
5533 (PPP3CC)
04380 Osteoclast differentiation
5533 (PPP3CC)
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
5533 (PPP3CC)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
5533 (PPP3CC)
05170 Human immunodeficiency virus 1 infection
5533 (PPP3CC)
05163 Human cytomegalovirus infection
5533 (PPP3CC)
05167 Kaposi sarcoma-associated herpesvirus infection
5533 (PPP3CC)
09171 Infectious disease: bacterial
05152 Tuberculosis
5533 (PPP3CC)
09164 Neurodegenerative disease
05010 Alzheimer disease
5533 (PPP3CC)
05014 Amyotrophic lateral sclerosis
5533 (PPP3CC)
05020 Prion disease
5533 (PPP3CC)
05022 Pathways of neurodegeneration - multiple diseases
5533 (PPP3CC)
09165 Substance dependence
05031 Amphetamine addiction
5533 (PPP3CC)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
5533 (PPP3CC)
09180 Brite Hierarchies
09181 Protein families: metabolism
01009 Protein phosphatases and associated proteins [BR:hsa01009]
5533 (PPP3CC)
Enzymes [BR:hsa01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.3 Phosphoric-monoester hydrolases
3.1.3.16 protein-serine/threonine phosphatase
5533 (PPP3CC)
Protein phosphatases and associated proteins [BR:hsa01009]
Protein serine/threonine phosphatases
Phosphoprotein phosphatases (PPPs)
Calcineurin (PPP3/ PP2B)
Catalytic subunits
5533 (PPP3CC)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
Position |
8:22441078..22541125
|
AA seq |
512 aa
MSGRRFHLSTTDRVIKAVPFPPTQRLTFKEVFENGKPKVDVLKNHLVKEGRLEEEVALKI
INDGAAILRQEKTMIEVDAPITVCGDIHGQFFDLMKLFEVGGSPSNTRYLFLGDYVDRGY
FSIECVLYLWSLKINHPKTLFLLRGNHECRHLTDYFTFKQECRIKYSEQVYDACMETFDC
LPLAALLNQQFLCVHGGMSPEITSLDDIRKLDRFTEPPAFGPVCDLLWSDPSEDYGNEKT
LEHYTHNTVRGCSYFYSYPAVCEFLQNNNLLSIIRAHEAQDAGYRMYRKSQATGFPSLIT
IFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEKVTEM
LVNVLNICSDDELISDDEAEGSTTVRKEIIRNKIRAIGKMARVFSILRQESESVLTLKGL
TPTGTLPLGVLSGGKQTIETATVEAVEAREAIRGFSLQHKIRSFEEARGLDRINERMPPR
KDSIHAGGPMKSVTSAHSHAAHRSDQGKKAHS |
NT seq |
1539 nt +upstreamnt +downstreamnt
atgtccgggaggcgcttccacctctccaccaccgaccgcgtcatcaaagctgtccccttt
cctccaacccaacggcttactttcaaggaagtatttgagaatgggaaacctaaagttgat
gttttaaaaaaccatttggtaaaggaaggacgactggaagaggaagtagccttaaagata
atcaatgatggggctgccatcctgaggcaagagaagactatgatagaagtagatgctcca
atcacagtatgtggtgatattcatggacaattctttgacctaatgaagttatttgaagtt
ggaggatcacctagtaacacacgctacctctttctgggtgactatgtggacagaggctat
ttcagtatagagtgtgtgctgtatttatggagtttaaagattaatcatcccaaaacattg
tttctgcttcggggaaatcatgaatgcaggcatcttacagactatttcaccttcaaacag
gaatgtcgaatcaaatattcggaacaggtgtatgatgcctgtatggagacatttgactgt
cttcctcttgctgccctcttaaaccagcagtttctctgtgtacatggaggaatgtcacct
gaaattacttctttagatgacattaggaaattagacaggtttacggaacctcccgccttt
ggacctgtgtgtgacctgctttggtctgatccctcagaggattatggcaatgagaagacc
ttggagcactatacccacaacactgtccgagggtgctcttatttctacagttaccctgca
gtttgtgaatttttgcagaacaataatttactatcaattatcagagcccatgaagcccaa
gatgctgggtatcgaatgtacaggaagagccaagccacaggctttccatcacttattaca
attttctctgcccccaattacctagatgtctataacaataaagctgctgtgttgaaatat
gaaaacaatgtcatgaatatcaggcagtttaactgttctccacacccctactggcttcca
aactttatggatgttttcacatggtctttgccttttgttggggaaaaagtcacagagatg
ctggtaaatgtgctcaacatatgctctgatgacgaactgatttctgatgatgaagcagaa
ggaagcactacagttcgtaaggagatcatcaggaataagatcagagccattgggaagatg
gcacgggtcttttcaattcttcggcaagaaagtgagagtgtgctgactctcaagggcctg
actcccacaggcacactccctctgggcgtcctctcaggaggcaagcagactatcgagaca
gccacagtagaagcggtagaggcccgggaagccatcagagggttctcgcttcagcacaag
atccggagttttgaagaagcgcgaggtctggaccgaattaatgagcgaatgccaccccga
aaggatagcatacacgctggtgggccaatgaaatctgtaacctcagcacactcacatgct
gcgcacaggagcgaccaagggaagaaagcccattcatga |